Afinitor-evertor (05 mg & 10 mg)

NOVARTIS

“Afinitor” contains the Drug / Molecule called “Everolimus”.

Everolimus, an immunosuppressive drug, is prescribed for the management of graft rejection in graft versus host disease (GVHD) in organ transplanted patients. Afinitor belongs to a class of medications called as protein kinase inhibitor. Afinitor is a potent inhibitor of the growth and proliferation of tumor cells, has shown to reduce glycolysis.

“Evertor” is the genric version of “Afinitor” and both contains same Drug / Molecule “Everolimus”.

Category:

Indication

Afinitor is commonly prescribed in kidney and / or liver transplanted, renal cancer patients.

Medical Uses:

  • Everolimus is approved for various conditions:
  • Advanced kidney cancer (US FDA approved in March 2009)
  • Prevention of organ rejection after renal transplant (US FDA April 2010)
  • Subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS) in patients who are not suitable for surgical intervention (US FDA October 2010)
  • Progressive or metastatic pancreatic neuroendocrine Tumors not surgically removable (May 2011)
  • Breast cancer in post-menopausal women with advanced hormone-receptor positive, HER2-negative type cancer, in conjunction with Exemestane (US FDA July 2012)
  • Prevention of organ rejection after liver transplant(Feb 2013)
  • Progressive, well-differentiated non-functional, neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin with unresectable, locally advanced or metastatic disease (US FDA February 2016).
  • Tuberous sclerosis compex-associated partial-onset seizures for adult and Pediatric patients aged 2 years and older. (US FDA April 2018).

Note

SIDE EFFECTS :

Non-Infectious Pneumonitis, Infections, Severe Hypersensitivity reactions, Angioedema, Renal Failure.

INTERACTION :

  • Avoid the concomitant use of P-gp and strong CYP3A4 inhibitors.
  • Patients taking concomitant ACE inhibitors with Afinitor may be at increased risk for angioedema. Avoid the concomitant use of ACE inhibitors with Afinitor.

OVERDOSE :

  • Do not use more than prescribed dose.
  • If you suspect you may have overdose, call your healthcare provider.
  • Do not take extra dose to make up for the missed dose.

Precaution

  • Afinitor is a prescription drug and should be used under proper medical guidance and advice.
  • Contraindicated in patients with clinical history of melanoma, clotting disorders, hepatic diseases.

Related products